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Abstract 
 
Tea catechin, (-) epigallocatechin gallate (EGCG), is one of the compounds that have been 
reported to act against obesity and diabetes. In order to determine the effect of EGCG on 
adipocyte differentiation, we treated 3T3-L1 preadipocytes with different kinds of catechins. 
Oil Red O staining showed that catechins, especially EGCG, significantly reduced intracellular 
lipid accumulation. Cell cycle analysis revealed that EGCG inhibited cell proliferation by 
disturbing the cell cycle during the clonal expansion of 3T3-L1. Real-time polymerase chain 
reaction (PCR) revealed that EGCG noticeably reduced mRNA expression of peroxisome 
proliferator-activated receptor gamma (PPAR), CCAAT/enhancer binding protein alpha 
(C/EBPα), and forkhead box class O (FoxO1). EGCG also caused a significant decrease in the 
transcriptional activity of FoxO1, a forkhead transcription factor class O1 involved in 
adipocyte differentiation, via the phosphoinositide-3-kinase (PI3K)/AKT and 
mitogen-activated protein kinase kinase-extracellular-signal-regulated kinase (MEK/ERK) 
pathways. These results suggest that EGCG suppresses the clonal expansion of adipocytes by 
inactivating FoxO1 via insulin signaling and stress-dependent MAP kinase pathways. 
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1. Introduction 
Obesity is generally considered as a major risk factor for diabetes, hypertension, and heart 
disease (David et al., 2001; Lee et al., 2005; Balkau et al., 2007). Obesity is caused by both 
genetic and environmental factors (Famer and Auwerx, 2004; Lee et al., 2005). The 
development of obesity is characterized by an increased number of fat cells and their lipids as 
a result of the mitogenesis and differentiation processes (Famer and Auwerx, 2004; Liao et al., 
2001). Further understanding of these mechanisms would aid in the prevention of obesity and 
associated diseases in humans.  
Tea is used as a common beverage across the world. It is well known that tea prevents 
many diseases, and longevity is often associated with the habit of drinking tea (Ahmad and 
Mukhtar, 1999; Crespy and Williamson, 2004; Liao et al., 2001; Lin et al., 1999; Mitcher et al., 
1997). Recently, it has been reported that (-) epigallocatechin gallate (EGCG) in green tea 
polyphenols prevents the incidence of cancer (Ahmad and Mukhtar, 1999; Lin et al., 1999; 
Mitcher et al., 1997), collagen-induced arthritis (Haqqi et al., 1999), oxidative stress-induced 
neurodegenerative diseases (Mendel and Youdim, 2004), and streptozotocin-induced diabetes 
(Song et al., 1999). In addition, EGCG can reduce body weight and body fat (Kao et al., 
2000a). Moreover, injection of EGCG into rats reduces their food uptake; lipid absorption; and 
blood triglyceride, cholesterol, and leptin levels, as well as stimulates energy expenditure, fat 
oxidation, high-density lipoprotein levels, and fecal lipid excretion (Dulloo et al., 1999; Kao et 
al., 2000a; Kao et al., 2000b; Liao et al., 2001). EGCG was found to reduce cell number and 
triacylglycerol content during the differentiation of preadipocytes (Kao et al., 2000a; Kim et 
al., 2010) and decreased the growth of 3T3-L1 preadipocytes. These evidences suggest that 
EGCG regulates the mitogenic, endocrine, and metabolic functions of adipocytes (Kao et al., 
2000a; Kim et al., 2010).  
The clonal cell lines of preadipocytes, such as mouse 3T3-L1 and 3T3-F442A (Gregoire 
et al., 1998; Rosen et al., 2000), require sequential events, including growth arrest of 
proliferating preadipocytes, reentry into the cell cycle with limited clonal expansion, and 
growth arrest associated with terminal differentiation. These changes in cell cycle require the 
expression of several adipogenic transcription factors, including an early increase in the 
expression of CCAAT/enhancer-binding protein (C/EBP) β and C/EBPδ followed by the 
induction of peroxisome proliferator-activated receptor (PPARγ) and C/EBPα (Mandrup and 
Lane, 1997; Morrison and Farmer, 2000; Rosen et al., 2000; Srujana et al., 2007). In a recent 
study, Nakae et al. reported that the over-expression of activated FoxO1 in adipocyte 
progenitor cells induces the expression of the cell cycle arrest-associated factor p21 and 
C/EBP inhibitor CHOP10; these disturb the progression of clonal expansion, thereby 
inhibiting adipocyte differentiation (Nakae et al., 2003). In another study, Munekata et al. 
reported that knockdown of FoxO1 mRNA expression markedly suppressed adipocyte 
differentiation (Munekata and Sakamoto, 2009). These observations suggest that FoxO1 plays 
an essential role in adipocyte differentiation.  
Insulin-like growth factor I (IGF-I) regulates mitogenesis, survival, and protein synthesis 
(Yin et al., 2009). IGF-I acts by binding to its cognate cell membrane receptor and then 
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activates several signaling intermediates, including members of the insulin receptor substrate 
(IRS) family and Shc (Src homolog and collagen homolog). Activation of IRS leads 
downstream to the activation of the PI3-kinase-Akt pathway, and the activation of Shc leads to 
the activation of the MEK/ERK pathway (Samani et al., 2007). Stimulation of the 
PI3-kinase-Akt pathway most often promotes cell growth, protein synthesis, and cell survival, 
whereas stimulation of the MEK/ERK pathway promotes cell proliferation and gene 
transcription (Yin et al., 2009). 
In this study, we analyzed the suppressive effect of EGCG on adipocyte differentiation 
mediated by the cell growth arrest at clonal expansion. In particular, we focused on the 
transcription factor FoxO1 that participates in clonal expansion arrest under the control of 
MEK/ERK and PI3K/AKT pathways. 
 
 
2. Materials and Methods 
2.1. Materials 
(-)-Epigallocatechin gallate (EGCG), (-)-epicatechin gallate (ECG), (-)-epigallocatechin 
(EGC), and (-)-catechin gallate (CG) were provided by Mitsui Norin (Tokyo, Japan). The 
catechins used in this study were dissolved in methanol and stored at –20 °C. PI3-K inhibitor 
(LY294002) was purchased from Echelon Biosciences Inc. (UT, USA), and MEK inhibitor 
(PD98059) was purchased from Calbiochem (Dermtadt, Germany). These inhibitors were 
dissolved in methanol and stored at –20 °C. 
 
2.2. Cell culture 
The 3T3-L1 cells (Health Science Research Resources Bank, Osaka, Japan) were cultured at 
37°C in Dulbecco’s modified Eagle’s medium (DMEM high-glucose) supplemented with 10% 
fetal bovine serum (FBS) (Sanko Junyaku, Tokyo, Japan). After the cells reached confluence, 
they were cultured for 2 days with 0.25 μM dexamethasone (Sigma-Aldrich, Missouri, U.S.A), 
0.5 mM 3-iso-butyl-1-methylxanthine (Sigma-Aldrich), and 10 μg/ml insulin (Wako, Osaka, 
Japan) (DMI induction). Next, the cells were cultured in the media containing 5 μg/ml insulin 
for 2 days and in standard culture media for 4 days (Rubin et al., 1978). 
 
2.3. Oil Red O staining 
Cells were cultured in media containing DMI and catechin (100 μM of EGCG, ECG, EGC, or 
CG) for 2 days and in standard culture media for 6 days. Cells were fixed with 4% 
paraformaldehyde for 1 h and then dyed with 3 mg/ml Oil Red O (Sigma-Aldrich) (in 60% 
isopropanol) for 10 min. After washing, the dye was eluted for 10 min with 100% isopropanol. 
The concentration of the eluted dye was determined from absorbance measurements (optical 
density (O.D.) 420 nm). 
 
2.4. Triglyceride assay 
Cells were lysed in lysis buffer (20 mM HEPES [pH 7.6], 420 mM NaCl, 1% Triton X-100, 
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0.1% SDS), and total fat was extracted by the Bligh and Dyer method (Bligh and Dyer, 1959). 
The cell extract (600 μl) was incubated in 2 ml methanol and 1 ml chloroform for 1 h, after 
which 1 ml chloroform and 1 ml of water were added, and samples were centrifuged briefly to 
collect the chloroform phase. This extract was dried overnight and dissolved in 10% 
triton-isopropanol solution. The quantity of triglyceride was measured according to the 
instructions for the triglyceride E-test Wako (Wako). The quantity of triglycerides (μg/μl) was 
normalized according to the each protein content. 
 
2.5. Measurement of reactive oxygen species (ROS) 
ROS were detected with the peroxide-sensitive fluorophore 2′, 7′-dichlorodihydrofluorescein 
diacetate (DCF-DA) (Wako). At the times indicated, DCF-DA dissolved in DMSO was added 
to cells at a final concentration of 5 μM. After incubation for 30 min at 37 °C, 3T3-L1 cells 
were washed with Hank’s Balanced Salt (HBBS, Sigma-Aldrich) and suspended in HBBS. 
Cells were observed under a BZ-Analyzer fluorescence microscope (KEYENCE, Osaka, 
Japan).  
 
2.6. Proliferation experiments 
Cells were cultured in the presence and absence of DMI and either EGCG (100 μM) or 
N-acetylcystein (NAC, 10 mM) for 2 days. Cells were collected after 0 and 2 days culture and 
then counted. 
 
2.7. FACS analysis 
Cells were cultured in the presence and absence of DMI and either EGCG (100 μM) or NAC 
(10 mM). Cells were cultured for 1 or 2 days, fixed in 75% ethanol, and then stained with the 
Guava Cell Cycle Reagent (Guava Technologies, CA, USA). The cells were analyzed by using 
a flow cytometry system with Guava PCA (Guava Technologies). 
 
2.8. Real-time PCR 
Quantitative polymerase chain reaction (PCR) analysis was performed with Gene Amp 5700 
Sequence Detection System (Applied Biosystems, CA, USA) and Thunder Birds SYBR qPCR 
mix reagent (TOYOBO, Osaka, Japan). PCR (95 °C for 15 s, 60 °C for 1 min, for 40 cycles) 
was performed using the specific primers (5′-AAA CTC TGG GAG ATT CTC CT-3′ and 
5′-TGG CAT CTC TGT GTC AAC-3′) for PPARγ, (5′-GCC AAA CTG AGA CTC TTC-3′ and 
5′-GGA AGC CTA AGT CTT AGC-3′) for C/EBPα, (5′-GAT CTA CGA GTG GAT GGT-3′ 
and 5′-CTT GCT GTG AAG GGA CAG-3′) for FoxO1, (5′-ACC AGG CTG AAG GAT CAC 
TGA GGA-3′ and 5′-GGC GTG GGA GTC TCA AAG GTG T-3′) for FoxO3a, and (5′- CTG 
TGC TGC TCA CCG AGG-3′ and 5′-AGC CTG GAT GGC TAC GTA-3′) for β-actin. β-actin 
was used as an internal standard for normalization of each sample. 
  
2.9. Luciferase assay 
COS7 cells were transfected with FoxO1-expressing plasmid (pcDNA3-FoxO1, 0.25 μg/4 cm 
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dish), luciferase reporter plasmid with consensus sequences of FoxO1 binding site (IRS-Luc, 
0.5 μg/4 cm dish), and β-galactosidase-expressing plasmid (PCMV-β-gal, 0.25 μg/4 cm dish). 
After 45 h of incubation, the cells were treated with EGCG (0, 10, 20, 50, or 100 μM) for 3 h. 
The luciferase reporter plasmid with a FoxO binding site of the catalase promoter 
(Catalase-Luc) was constructed. The stable 3T3-L1 cells carrying Catalase-Luc were prepared 
(3T3-L1/Catalase-Luc). These cells were treated with catechin (100 μM each of EGCG, ECG, 
and EGC) and NAC (10 mM) for 2 days. After brief centrifugation (12,000 rpm; 2 min; 
MX-100; Tomy, Tokyo, Japan) of the cell lysate, supernatant was collected and mixed with 
Luciferase Assay Reagent (Promega, Wiscony, USA). Luciferase activity was measured with 
Luminometer Microlumat LB69p (Berthold Technology, Wildbad, Germany).  
 
 
3. Results 
3.1. Effect of catechin on fat accumulation 
In our previous study, we have examined the effects of catechins (EGCG, ECG, EGC and CG) 
on 3T3-L1 cells at various doses (0, 5, 50, 100, 200 μM) and at various developmental periods 
(0-2, 2-4 and 0-8 days after DMI induction) (Kim et al., 2010). From these data, we identified 
that exposure of 100 μM EGCG at 0-2 days of differentiation reduced fat accumulation most 
efficiently, without toxicity. In this study, we have exposed 3T3-L1 cells with catechin (EGCG, 
ECG, EGC, or CG, 100 μM) and DMI for 2 days. After 6 days of culture, cells were stained 
with Oil Red O, and the absorbance of the extracted dye was measured (OD, 420 nm). As 
observed in Figure 1A, catechin suppressed Oil Red O-stained lipid level, especially ECG 
showed the strongest suppressive effect. Under the same conditions, we determined 
triglyceride accumulation (Fig. 1B) and found that catechin efficiently reduced intracellular 
level of triglyceride. Because catechins belong to antioxidant compounds, the fat level in 
adipocytes is possibly changed by their antioxidative activity. Accordingly, we treated cells 
with N-acetylcysteine (NAC), one of the commonly used antioxidants, which also resulted in 
reduced triglyceride accumulation (Fig. 1B). These results suggest that adipocyte 
differentiation was possibly prevented by antioxidant effect of catechin. 
 
3.2. Effect of EGCG on intracellular ROS 
3T3-L1 cells were treated with DMI and either EGCG (100 μM) or NAC (10 mM) for 2 days, 
after which cells were cultured in media containing insulin for 2 days. In the absence of EGCG 
or NAC, 3T3-L1 cells gradually produced intracellular reactive oxygen species (ROS) along 
with differentiation (Fig. 2). However, EGCG and NAC efficiently removed the intracellular 
ROS in differentiating 3T3-L1 cells. These results indicate that EGCG and NAC 
simultaneously reduced ROS and lipid accumulation in DMI-induced 3T3-L1 cells.   
 
3.3. Effect of EGCG on proliferation 
3T3-L1 cells were treated with EGCG (100 μM) or NAC (10 mM) in the presence and absence 
of DMI for 2 days. The proliferation of 3T3-L1 cells was not changed by EGCG and NAC in 
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the absence of DMI induction (DMI (-)) (Fig. 3). It is generally considered that, after the DMI 
induction, 3T3-L1 proliferates twice (so called clonal expansion) to lead to terminal 
differentiation (Nakae et al., 2003). Under the DMI induction, the cell number of 3T3-L1 cells 
increased drastically, and cell growth was significantly inhibited by EGCG treatment (DMI 
(+)). On the other hand, NAC exerted only weak suppressive effect on cell proliferation of 
DMI-induced 3T3-L1 preadipocytes. Accordingly, these results indicate that EGCG strongly 
suppressed the clonal expansion of differentiating 3T3-L1 cells.  
 
3.4. Effect of catechin on cell cycle 
Under the same conditions, the effect of EGCG on cell cycle status was analyzed using flow 
cytometry. As shown in Figure 4, EGCG and NAC did not affect the cell cycle rate of 3T3-L1 
in the absence of DMI. On the other hand, after DMI-treatment, EGCG disturbed the cell cycle 
of 3T3-L1 cells (DMI (+)). In DMI-induced 3T3-L1, EGCG, and not NAC, reduced the cell 
population at the G0/G1 phase and increased the cell population at the S phase (DMI (+)). 
These results indicate that EGCG specifically inhibited the clonal expansion of differentiating 
3T3-L1 cells. 
 
3.5. Effect of catechin on mRNA expression of clonal expansion-related gene  
To elucidate the signaling pathway through which EGCG acts on the clonal expansion of 
3T3-L1, we performed real time-PCR and analyzed the endogenous mRNA level of clonal 
expansion-related genes, including PPARγ, C/EBPα, FoxO1, and FoxO3. As observed in 
Figure 5, EGCG significantly reduced the mRNA expression of PPARγ, C/EBPα, and FoxO1, 
but did not reduce the mRNA expression of FoxO3. In contrast, NAC did not change the 
mRNA level of these genes. These results suggest that EGCG was specifically involved in the 
clonal expansion by reducing the mRNA expression of PPARγ, C/EBPα, and FoxO1. 
 
3.6. Effect of EGCG on the transcriptional activity of FoxO1 
To further analyze the effect of EGCG on FoxO1, we analyzed the transcriptional activity of 
FoxO1. COS7 cells were transfected transiently with FoxO1-expressing plasmid 
(pcDNA3-FoxO1), luciferase reporter plasmid with consensus sequences of FoxO1 binding 
site (IRS-Luc), and β-galactosidase-expressing plasmid (PCMV-β-gal). These cells were 
treated with EGCG (0, 10, 20, 50, and 100 μM) for 3 h and analyzed for luciferase assay. At 
the concentration of 100 μM, EGCG reduced the transcriptional activity of FoxO1 in COS7 
cells (Fig. 6A). We also prepared 3T3-L1 cells that stably expressed the luciferase reporter 
plasmids with a FoxO1 binding site of catalase promoter (3T3-L1/Catalase-Luc). As shown in 
Figure 6B, EGCG and NAC reduced the transcriptional activity of FoxO1. To elucidate the 
signaling mechanism underlying the effect of EGCG on FoxO1, we used the specific 
inhibitors against PI3K (LY294002) and MEK (PD98059). EGCG reduced the transcriptional 
activity of FoxO1 after the treatment with LY294002 or PD98059, whereas NAC failed to 
suppress FoxO1 activity in the presence of PD98059. In contrast to these results, EGCG lost 
its suppressive effect on FoxO1 after the co-treatment with LY294002 and PD98059. These 
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results suggest that EGCG suppresses the clonal expansion of differentiating adipocytes by 
reducing the transcriptional activity of FoxO1 via the PI3K/AKT and MEK/ERK pathways. 
 
 
4. Discussion 
Our results clearly indicate that catechin suppressed the differentiation of 3T3-L1 
preadipocytes. NAC, which also has antioxidant activities, similarly suppressed the 
differentiation of 3T3-L1 cells (Fig. 1). These data suggest that antioxidant activities of EGCG 
suppress the differentiation of 3T3-L1 cells. 
Mature adipocytes produce higher levels of ROS compared with other tissues, including 
liver, skeletal muscle, and aorta (Shimomura et al., 2007). Thus, it is possible that mature 
adipocytes could be major sources of ROS that accelerate the differentiation of preadipocytes. 
Recently, it was reported that ROS facilitate adipocyte differentiation by inducing mitotic 
clonal expansion (Lee et al., 2009). Our studies showed that intracellular ROS level increased 
along with differentiation of 3T3-L1 (Fig. 2), and EGCG and NAC clearly reduced the ROS 
generated from mitochondoria in developing adipocytes, suggesting that EGCG and NAC 
possibly suppress adipocyte differentiation by lowering intracellular ROS. However, these 
results did not clearly indicate whether EGCG and NAC reduce ROS level by inhibiting the 
differentiation or suppress differentiation by reducing the ROS level. Recently, it was reported 
that various phytochemicals like genistein, docosahexaenoic acid, epigallocatehin gallate, 
quercetin and resveratrol inhibit adipogenesis or induce apoptosis (Srujana et al., 2007). For 
instance, genistein suppressed mitotic clonal expansion of postconfluent 3T3-L1 preadipocytes 
(Harmon and Harp, 2001). To understand why EGCG suppresses adipocyte differentiation, we 
analyzed the effect of EGCG on cell proliferation and cell cycle (Figs. 3, 4). These analyses 
suggest that EGCG inhibited cell proliferation and disturbed the cell cycle, whereas NAC 
partially affected the cell cycle (Fig. 4), indicating that EGCG possibly reduces intracellular 
ROS by suppressing clonal expansion of the DMI-treated 3T3-L1 cells. 
Furthermore, we examined the effect of EGCG on the endogenous mRNA expression of 
clonal expansion-related genes, including PPARγ, C/EBPα, and FoxO1. EGCG substantially 
reduced mRNA expression of PPARγ, C/EBPα, and FoxO1 (Fig. 5), whereas NAC did not. 
These data suggest that EGCG may arrest clonal expansion by reducing the expression of 
clonal expansion-related genes and thereby suppress differentiation. Next, we focused on 
FoxO transcription factors. It has been reported that the FoxO family inhibits the clonal 
expansion stage (Nakae et al., 2003). Nakae et al. reported that FoxO1 suppresses adipocyte 
differentiation, whereas we clarified the fact that FoxO1 is essential to facilitate the 
differentiation of 3T3-L1 (Munekata and Sakamoto, 2009). Because EGCG reduced FoxO1 
transcriptional activity in COS7 cells (Fig. 6A) and 3T3-L1 cells (Fig. 6B), it was suggested 
that suppressive effect of EGCG on adipocyte differentiation is at least partially caused by the 
inactivation of FoxO. Our data suggested that EGCG possibly reduces intracellular ROS level 
by inhibiting clonal expansion of 3T3-L1. In our previous study, we found that HepG2 cells 
externally exposed to ROS showed increased lipid accumulation (Sekiya et al., 2008). Because 
 9
NAC shows strong antioxidant activity, it possibly reduces lipogenic activity by lowering 
intracellular ROS level in 3T3-L1 cells.  
To clarify the mechanism underlying the inactivation of FoxO1, we analyzed the 
involvement of PI3K/AKT and MEK/ERK pathways in EGCG-treated 3T3-L1 cells (Fig. 6B). 
The suppressive effect of EGCG on FoxO1 remained unchanged by the treatment with PI3K 
inhibitor (LY294002) or MEK inhibitor (PD98059). However, EGCG lost its effect on FoxO1 
in the presence of both the inhibitors. We speculated that insulin activates the IRS family and 
Shc: activated IRS leads to the activation of the PIK/AKT pathway, and activated Shc leads to 
the activation of the MEK/ERK pathway. These results indicate that EGCG activates the 
PI3K/AKT pathway and inactivates the MEK/ERK pathway, thereby reducing the 
transcriptional activity of FoxO1. Because catechin did not affect the expression of Gadd45 
(data not shown), we ignored the participation of WNT signaling pathway. 
These findings indicate that EGCG specifically suppresses differentiation by lowering the 
endogenous mRNA expression of clonal expansion-related genes, and particularly, that EGCG 
reduces the transcription activity of FoxO1 via the MEK/ERK and PI3K/AKT pathways. 
Future studies on the association between EGCG and FoxO1 may aid in the prevention of 
diabetes and obesity.   
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Figure Legends 
 
Fig. 1. Effect of catechin on adipocyte differentiation 
(A) Adipose accumulation was observed in the cells treated with catechin. Cells were treated 
with catechin (100 μM of EGCG, ECG, EGC, or CG) and DMI for 2 days. Then, cells were 
cultured for 2 days with insulin (5 μg/ml) and for 4 days in standard medium, after which cells 
were fixed for Oil Red O staining. The cells stained with Oil Red O were treated with 
isopropanol to extract the dye, and the concentration of eluted dye was determined by 
measuring the absorbance at an optical density of 420 nm. An error bar shows the standard 
deviation of the mean, n = 3; **P < 0.05. (B) Cells were treated by EGCG (100 μM), ECG 
(100 μM), or NAC (10 mM) with DMI for 2 days. Then, cells were cultured for 2 days with 
insulin (5 μg/ml) and for 4 days in standard medium. Lipid was then extracted using the Bligh 
and Dyer methods (Bligh and Dyer, 1959). Triglyceride level was corrected by total protein 
level. An error bar shows the standard deviation of the mean, n = 3; **P < 0.05. 
 
Fig. 2. Effect of EGCG on the level of ROS 
Cells were treated with either EGCG (100 μM) or NAC (10 mM) with DMI for 2 days. Then, 
cells were cultured for 2 days with insulin (5 μg/ml) in the standard medium. After 0, 2, or 4 
days culture, cells were treated with DCF-DA (5 μM) for 30 min and observed under a 
fluorescence microscope. 
 
Fig. 3. Effect of EGCG on cell proliferation 
Cells were treated with EGCG (100 μM) or NAC (10 mM) in the absence and presence of 
DMI. After 0 or 2 days culture, cells were detached and counted. Error bars show standard 
deviation of the mean, n = 3; **P < 0.05. 
 
Fig. 4. Effect of EGCG on cell cycle 
Cells were treated with EGCG (100 μM) or NAC (10 mM) in the absence and presence of 
DMI. After 1 or 2 days culture, cells were detached and fixed. Changes in DNA content were 
analyzed by a flow cytometry system with Guava PCA.  
 
Fig. 5. Effect of catechin on mRNA expression 
The mRNA level of each gene was analyzed by real-time PCR. Cells were treated with EGCG 
(100 μM) or NAC (10 mM) with DMI for 2 days and then cultured for 6 days. RNA was 
prepared and subjected to cDNA synthesis for real-time PCR assay.  
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Fig. 6. Effect of EGCG on transcriptional activity of FoxO1  
(A) Luciferase activity of the ECGC-treated cells is shown. Cells were transfected with 
FoxO1-expressing plasmid (pcDNA3-FoxO1, 0.25 μg/4-cm dish), luciferase reporter plasmid 
with a consensus sequence of FoxO1 binding site (IRS-Luc, 0.5 μg/dish), and β-galactosidase 
expressing plasmid (PCMV-β-gal, 0.25 μg/dish). After 45 hours of incubation, cells were 
treated with EGCG (0, 10, 20, 50, or 100 μM) for 3 h and analyzed for luciferase activity. 
Luciferase activity was corrected by β-galactosidase activity. An error bar shows the standard 
deviation of the mean, n = 6; **P < 0.05. (B) The luciferase activity of the EGCG-treated cells 
is shown. 3T3-L1 cells carrying luciferase reporter plasmid with a FoxO1 binding site 
(3T3-L1/Catalase-Luc) were pretreated with PI3-K inhibitor (20 μM; LY294002) and MEK 
inhibitor (50 μM; PD98059) for 2 h, and then treated with EGCG (100 μM) and NAC (10 
mM) for 2 days. An error bar shows the standard deviation of the mean, n = 3; **P < 0.05.  
 






